Spots Global Cancer Trial Database for opevesostat
Every month we try and update this database with for opevesostat cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | NCT06136624 | Prostate Cancer... | Opevesostat Abiraterone ace... Enzalutamide Hydrocortisone Fludrocortisone... Prednisone Dexamethasone | - | Merck Sharp & Dohme LLC | |
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | NCT06136598 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | NCT06104449 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone... Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | NCT06136598 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | NCT06104449 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone... Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | NCT06136624 | Prostate Cancer... | Opevesostat Abiraterone ace... Enzalutamide Hydrocortisone Fludrocortisone... Prednisone Dexamethasone | - | Merck Sharp & Dohme LLC |